Platelets, complement and tissue inflammation

References

• Rendu F., Brohard-Bohn B.. The platelet release reaction: granules' constituents, secretion and functions. Platelets. 2001; 12:261–273.
   PubMed Web of Science ®Google Scholar
• May A. E., Kalsch T., Massberg S., Herouy Y., Schmidt R., Gawaz M.. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation. 2002; 106:2111–2117.
   PubMed Web of Science ®Google Scholar
• Walz D. A., Wu V. Y., de Lamo R., Dene H., McCoy L. E.. Primary structure of human platelet factor 4. Thromb. Res.. 1977; 11:893–898.
   PubMed Web of Science ®Google Scholar
• Kirk A. D., Morrell C. N., Baldwin W. M.3rd. Platelets influence vascularized organ transplants from start to finish. Am. J. Transplant.. 2009; 9:14–22.
   PubMed Web of Science ®Google Scholar
• Duffau P., Seneschal J., Nicco C., Richez C., Lazaro E., Douchet I., Bordes C., Viallard J. F., Goulvestre C., Pellegrin J. L., . Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci. Transl. Med.. 2010; 2:47ra63.
   PubMed Web of Science ®Google Scholar
• Collins C. E., Rampton D. S.. Review article: Platelets in inflammatory bowel disease–pathogenetic role and therapeutic implications. Aliment Pharmacol. Ther.. 1997; 11:237–247.
   PubMed Web of Science ®Google Scholar
• Franks Z. G., Campbell R. A., Weyrich A. S., Rondina M. T.. Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke. Ann. N.Y. Acad. Sci.. 2010; 1207:11–17.
   PubMed Web of Science ®Google Scholar
• Lapchak P. H., Kannan L., Ioannou A., Rani P., Karian P., Dalle Lucca J. J., Tsokos G. C.. Platelets orchestrate remote tissue damage after mesenteric ischemia-reperfusion. Am. J. Physiol. Gastrointest. Liver Physiol.. 2012; 302:G888–G897.
   Google Scholar
• Peerschke E. I., Yin W., Grigg S. E., Ghebrehiwet B.. Blood platelets activate the classical pathway of human complement. J. Thromb. Haemost.. 2006; 4:2035–2042.
   PubMed Web of Science ®Google Scholar
• Del Conde I., Cruz M. A., Zhang H., Lopez J. A., Afshar-Kharghan V.. Platelet activation leads to activation and propagation of the complement system. J. Exp. Med.. 2005; 201:871–879.
   PubMed Web of Science ®Google Scholar
• Hamad O. A., Ekdahl K. N., Nilsson P. H., Andersson J., Magotti P., Lambris J. D., Nilsson B.. Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J. Thromb. Haemost.. 2008; 6:1413–1421.
   PubMedGoogle Scholar
• Morel O., Toti F., Hugel B., Freyssinet J. M.. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol.. 2004; 11:156–164.
   PubMedGoogle Scholar
• Zeiger F., Stephan S., Hoheisel G., Pfeiffer D., Ruehlmann C., Koksch M.. P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul. Fibrinolysis. 2000; 11:723–728.
   PubMed Web of Science ®Google Scholar
• Choudhury A., Chung I., Blann AD., Lip GY.. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. Chest. 2007; 131:809–815.
   PubMed Web of Science ®Google Scholar
• Piccin A., Murphy W. G., Smith O. P.. Circulating microparticles: pathophysiology and clinical implications. Blood Rev.. 2007; 21:157–171.
   PubMed Web of Science ®Google Scholar
• Yin W., Ghebrehiwet B., Peerschke E. I.. Expression of complement components and inhibitors on platelet microparticles. Platelets. 2008; 19:225–233.
   PubMed Web of Science ®Google Scholar
• Tschopp J., Jenne D. E., Hertig S., Preissner K. T., Morgenstern H., Sapino AP., French L.. Human megakaryocytes express clusterin and package it without apolipoprotein A-1 into alpha-granules. Blood. 1993; 82:118–125.
   PubMed Web of Science ®Google Scholar
• Tsokos G. C.. Systemic lupus erythematosus. N. Engl. J. Med.. 2011; 365:2110–2121.
   PubMed Web of Science ®Google Scholar
• Navratil J. S., Manzi S., Kao A. H., Krishnaswami S., Liu C. C., Ruffing M. J., Shaw P. S., Nilson A. C., Dryden E. R., Johnson J. J., . Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum.. 2006; 54:670–674.
   PubMed Web of Science ®Google Scholar
• McInnes I. B., Schett G.. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med.. 2011; 365:2205–2219.
   PubMed Web of Science ®Google Scholar
• Boilard E., Nigrovic P. A., Larabee K., Watts G. F., Coblyn J. S., Weinblatt M. E., Massarotti E. M., Remold-O'Donnell E., Farndale R. W., Ware J., . Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science. 2010; 327:580–583.
   PubMed Web of Science ®Google Scholar
• Postlethwaite A. E., Chiang T. M.. Platelet contributions to the pathogenesis of systemic sclerosis. Curr. Opin. Rheumatol.. 2007; 19:574–579.
   PubMed Web of Science ®Google Scholar
• Kahaleh M. B., Osborn I., Leroy E. C.. Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma. Ann. Intern. Med.. 1982; 96:610–613.
   PubMed Web of Science ®Google Scholar
• Goodfield M. J., Orchard M. A., Rowell N. R.. Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis. Br. J. Haematol.. 1993; 84:675–680.
   PubMedGoogle Scholar
• Pattanaik D., Brown M., Postlethwaite A. E.. Vascular involvement in systemic sclerosis (scleroderma). J. Inflamm. Res.. 2011; 4:105–125.
   PubMedGoogle Scholar
• Agache I., Radoi M., Duca L.. Platelet activation in patients with systemic scleroderma—Pattern and significance. Rom. J. Intern. Med.. 2007; 45:183–191.
   PubMedGoogle Scholar
• Yoshizaki A., Komura K., Iwata Y., Ogawa F., Hara T., Muroi E., Takenaka M., Shimizu K., Hasegawa M., Fujimoto M., . Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: Association with disease severity. J. Clin. Immunol.. 2009; 29:180–189.
   PubMed Web of Science ®Google Scholar
• Chiang T. M., Takayama H., Postlethwaite A. E.. Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis. Thromb. Res.. 2006; 117:299–306.
   PubMedGoogle Scholar
• Kowal-Bielecka O., Kowal K., Lewszuk A., Bodzenta-Lukaszyk A., Walecki J., Sierakowski S.. Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis. Ann. Rheum. Dis.. 2005; 64:484–486.
   PubMed Web of Science ®Google Scholar
• Bamias G., Cominelli F.. Immunopathogenesis of inflammatory bowel disease: Current concepts. Curr. Opin. Gastroenterol.. 2007; 23:365–369.
   PubMed Web of Science ®Google Scholar
• Harries A. D., Beeching N. J., Rogerson S. J., Nye F. J.. The platelet count as a simple measure to distinguish inflammatory bowel disease from infective diarrhoea. J. Infect.. 1991; 22:247–250.
   PubMed Web of Science ®Google Scholar
• Kapsoritakis A. N., Koukourakis M. I., Sfiridaki A., Potamianos S. P., Kosmadaki M. G., Koutroubakis I. E., Kouroumalis E. A.. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am. J. Gastroenterol.. 2001; 96:776–781.
   PubMed Web of Science ®Google Scholar
• Collins C. E., Cahill M. R., Newland A. C., Rampton D. S.. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology. 1994; 106:840–845.
   PubMed Web of Science ®Google Scholar
• Sankey E. A., Dhillon A. P., Anthony A., Wakefield A. J., Sim R., More L., Hudson M., Sawyerr A. M., Pounder R. E.. Early mucosal changes in Crohn's disease. Gut. 1993; 34:375–381.
   PubMed Web of Science ®Google Scholar
• Danese S., de la Motte C., Sturm A., Vogel J. D., West G. A., Strong, S. A. S. A., Katz J. A., Fiocchi C.. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology. 2003; 124:1249–1264.
   PubMed Web of Science ®Google Scholar
• Suzuki K., Sugimura K., Hasegawa K., Yoshida K., Suzuki A., Ishizuka K., Ohtsuka K., Honma T., Narisawa R., Asakura H.. Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand. J. Gastroenterol.. 2001; 36:1301–1306.
   PubMedGoogle Scholar
• Ioannou A., Dalle Lucca J., Tsokos G. C.. Immunopathogenesis of ischemia/reperfusion-associated tissue damage. Clin. Immunol.. 2011; 141:3–14.
   PubMedGoogle Scholar
• Lapchak P. H., Ioannou A., Kannan L., Rani P., Dalle Lucca J. J., Tsokos G. C.. Platelet-associated CD40/CD154 mediates remote tissue damage after mesenteric ischemia/reperfusion injury. PLoS One. 2012; 7:e32260.
   Google Scholar
• Lapchak P. H., Ioannou A., Rani P., Lieberman L. A., Yoshiya K., Kannan L., Lucca J. J., Kowalska M. A., Tsokos G. C.. The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injury. PLoS One. 2012; 7:e39934.
   PubMed Web of Science ®Google Scholar
• Lapchak P. H., Kannan L., Rani P., Pamuk O. N., Ioannou A., Dalle Lucca J. J., Pine P., Tsokos G. C.. Inhibition of Syk activity by R788 in platelets prevents remote lung tissue damage after mesenteric ischemia-reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol.. 2012; 302:G1416–G1422.
   Google Scholar